Добірка наукової літератури з теми "Clostridium difficile (C. difficile)"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Clostridium difficile (C. difficile)".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "Clostridium difficile (C. difficile)"
Adhikari, Sushil. "Clostridium Difficile." Nepalese Medical Journal 1, no. 1 (June 22, 2018): 43–46. http://dx.doi.org/10.3126/nmj.v1i1.20400.
Повний текст джерелаJohnson, S. "Clostridium difficile Toxins and Severe C. difficile Infection." Journal of Infectious Diseases 205, no. 3 (December 5, 2011): 353–54. http://dx.doi.org/10.1093/infdis/jir752.
Повний текст джерелаHossain, M., TJ Crook, and SR Keoghane. "Clostridium Difficile in Urology." Annals of The Royal College of Surgeons of England 90, no. 1 (January 2008): 36–39. http://dx.doi.org/10.1308/003588408x242358.
Повний текст джерелаItoh, K., W. K. Lee, H. Kawamura, T. Mitsuoka, and T. Magaribuchi. "Intestinal bacteria antagonistic to Clostridium difficile in mice." Laboratory Animals 21, no. 1 (January 1, 1987): 20–25. http://dx.doi.org/10.1258/002367787780740662.
Повний текст джерелаStein, R. B. "Clostridium difficile Toxoid Vaccine in Recurrent C. difficile–Associated Diarrhea." Yearbook of Gastroenterology 2006 (January 2006): 177–78. http://dx.doi.org/10.1016/s0739-5930(08)70370-2.
Повний текст джерелаSougioultzis, Stavros, Lorraine Kyne, Denise Drudy, Sarah Keates, Seema Maroo, Charalabos Pothoulakis, Paul J. Giannasca, et al. "Clostridium difficile toxoid vaccine in recurrent C. difficile-associated diarrhea." Gastroenterology 128, no. 3 (March 2005): 764–70. http://dx.doi.org/10.1053/j.gastro.2004.11.004.
Повний текст джерелаMohamed, Abdalla, Vanessa Sostre, Hiren Patel, Prem Patel, Luis C. Ortiz, and Walid J. Baddoura. "Clostridium difficile Causing Empyema." Case Reports in Gastroenterology 12, no. 3 (October 24, 2018): 633–39. http://dx.doi.org/10.1159/000493184.
Повний текст джерелаAndroga, Grace O., Alan M. McGovern, Briony Elliott, Barbara J. Chang, Timothy T. Perkins, Niki F. Foster, and Thomas V. Riley. "Evaluation of the Cepheid Xpert C. difficile/Epiand Meridian Bioscienceillumigene C. difficile Assays for Detecting Clostridium difficile Ribotype 033 Strains." Journal of Clinical Microbiology 53, no. 3 (December 17, 2014): 973–75. http://dx.doi.org/10.1128/jcm.03297-14.
Повний текст джерелаSanghi, P., A. Oates, and A. K. Scott. "Antibiotic Policy and Clostridium Difficile." Age and Ageing 24, suppl 1 (January 1, 1995): P27—P28. http://dx.doi.org/10.1093/ageing/24.suppl_1.p27-c.
Повний текст джерелаBartlett, John G. "Detection of Clostridium difficile Infection." Infection Control & Hospital Epidemiology 31, S1 (November 2010): S35—S37. http://dx.doi.org/10.1086/655999.
Повний текст джерелаДисертації з теми "Clostridium difficile (C. difficile)"
Hecker, Kim Ione. "Bleach-It-Away Clostridium difficile." ScholarWorks, 2018. https://scholarworks.waldenu.edu/dissertations/5471.
Повний текст джерелаMaulner, Stéphanie. "Les endolysines de Clostridium difficile : Potentiel thérapeutique pour traiter les infections à C. difficile (ICD)." Mémoire, Université de Sherbrooke, 2010. http://savoirs.usherbrooke.ca/handle/11143/4059.
Повний текст джерелаTaibi, Fatima. "Études des riborégulateurs c-di-GMP chez Clostridium difficile." Mémoire, Université de Sherbrooke, 2016. http://hdl.handle.net/11143/8785.
Повний текст джерелаSundström, Joakim. "Clostridium difficile – ett växande problem : Om sjuksköterskans arbete för att förebygga spridning av C. difficile i slutenvården." Thesis, Mittuniversitetet, Avdelningen för omvårdnad, 2013. http://urn.kb.se/resolve?urn=urn:nbn:se:miun:diva-20170.
Повний текст джерелаVan, Tyle Kendall M. "The Molecular Epidemiology of Clostridium difficile: Description of Clostridium difficile Associated Diarrhea (CDAD) Following a Formulary Change From Levofloxacin to Gatifloxacin." The University of Arizona, 2006. http://hdl.handle.net/10150/624511.
Повний текст джерелаBackground: The processes’ underlying a recent rise in the rate of Clostridium difficile associated diarrhea (CDAD) at the Southern Arizona Veterans Administration Health Care System (SAVAHS) is unclear. Past changes to formulary in workhorse oral flouroquinolone from levofloxacin to gatifloxacin are under scrutiny. An infection-control component was also possible. Methods: 142 patients suspected of having CDAD had stool specimens submitted for toxin assay from late July to late Oct of 2004. A retrospective chart review was performed using the Veterans Administration Computerized Patient Record System (CPRS) to examine total antibiotic use in the three months prior to having specimens submitted for laboratory toxin analysis. A subset-analysis was performed on 100 specimens submitted for toxin analysis. Parallel culture was performed and 9 isolates of C. difficile were obtained for molecular analysis and fingerprinting. Results: Of the 142 patients sampled, 20 tested positive for C. difficile toxin with the remaining 122 patients testing negative. Antibiotic usage was categorized by total antibiotic use and gatifloxacin use. 98 patients received at least 1 antibiotic within the preceding 3 months with 44 patients receiving no antibiotic therapy of any kind. Of the 98 patients that received antibiotic therapy, 44 received gatifloxacin, however, all of these patients also received at least one other antibiotic. Of the nine isolates fingerprinted, two distinct genetic clusters were identified.
Wroe, Allison J. "Immune response to Clostridium difficile infection and an investigation of the mechanisms of moxifloxacin resistance in clinical C. difficile isolates." Thesis, University of Edinburgh, 2010. http://hdl.handle.net/1842/4452.
Повний текст джерелаShaw, Claire M. "Inactivation of Clostridium difficile spores in the healthcare environment using hydrogen peroxide vapour." Thesis, Loughborough University, 2013. https://dspace.lboro.ac.uk/2134/12460.
Повний текст джерелаStehmer, Theresa, and Jackie Campbell. "Evaluation of combination therapy for Clostridium difficile infections at an academic hospital." The University of Arizona, 2012. http://hdl.handle.net/10150/623589.
Повний текст джерелаSpecific Aims: The incidence of non-response, recurrence, relapse, and rate of complications of Clostridium difficile infections treated with combination of metronidazole and vancomycin versus vancomycin or metronidazole alone over a one-year period by treatment and strain type (i.e. NAP1/BI/027) were evaluated. The incidence of mortality in patients with moderate to severe Clostridium difficile associated diarrhea prescribed metronidazole, vancomycin, or combination metronidazole plus vancomycin as initial therapy was also determined. Additionally, significant factors associated with the use of combination vancomycin-metronidazole as initial therapy for moderate to severe CDAD were characterized. Methods: T This retrospective medical record review has been approved by the Institutional Review Board. Adult patients with stool specimens tested for detection of Clostridium difficile toxin B by PCR between April 2010 and March 2011 at a tertiary care, academic medical center were evaluated. Patients were included in the study if diagnosed with moderate to severe disease and received either monotherapy with metronidazole, monotherapy with oral vancomycin, or combination therapy with metronidazole and oral vancomycin for at least 80% of the first 10 days of treatment. Patients who are discharged alive within 72 hours of admission or who received therapy for less than 48 hours were excluded. Main Results: All patients (N=411) with laboratory evidence of Clostridium difficile during the study time period were evaluated. A total of 26 subjects who received oral vancomycin monotherapy and 56 subjects who received oral vancomycin along with metronidazole for at least 80% of the first 10 days of treatment were identified. Of the subjects who received oral vancomycin monotherapy during the first ten days of therapy, 5 (19%) were classified has a treatment failure or died within the first 21 days of therapy and 5 (19%) had either a recurrence or reappearance of Clostridium difficile associated diarrhea between 22 and 65 days post start of therapy. Of the subjects who received a combination of oral vancomycin and metronidazole during the first 10 days of therapy, 14 (25%) were classified has a treatment failure or died within the first 21 days of therapy and 22 (39%) had either a recurrence or reappearance of Clostridium difficile associated diarrhea between 22 and 65 days post start of therapy. In the combination therapy group, 5 (9%) were reported to have an ileus, toxic megacolon, or necrotic bowel during the first 10 days of therapy. Conclusions: In this study, the subjects who received a combination of oral vancomycin and metronidazole had higher rates of clinical failure, death, and recurrence than subjects who received monotherapy. Current guideline statements recommend combination therapy only in patients with an ileus with Clostridium difficile-associated diarrhea.
Feliciano, Lisa. "Clostridium difficile Infection (CDI): Use of Preventive Bundle to Decrease CDI Incidences." ScholarWorks, 2018. https://scholarworks.waldenu.edu/dissertations/5188.
Повний текст джерелаSoavelomandroso, Anna P., Françoise Gaudin, Sandra Hoys, Valérie Nicolas, Gayatri Vedantam, Claire Janoir, and Sylvie Bouttier. "Biofilm Structures in a Mono-Associated Mouse Model of Clostridium difficile Infection." FRONTIERS MEDIA SA, 2017. http://hdl.handle.net/10150/626057.
Повний текст джерелаКниги з теми "Clostridium difficile (C. difficile)"
C. difficile treatments & remedies your doctor isn't telling you. Port Townsend, WA: Embrace Health, 2014.
Знайти повний текст джерелаRoberts, Adam P., and Peter Mullany, eds. Clostridium difficile. New York, NY: Springer New York, 2016. http://dx.doi.org/10.1007/978-1-4939-6361-4.
Повний текст джерелаAktories, Klaus, and Tracy D. Wilkins, eds. Clostridium difficile. Berlin, Heidelberg: Springer Berlin Heidelberg, 2000. http://dx.doi.org/10.1007/978-3-662-06272-2.
Повний текст джерелаMullany, Peter, and Adam P. Roberts, eds. Clostridium difficile. Totowa, NJ: Humana Press, 2010. http://dx.doi.org/10.1007/978-1-60327-365-7.
Повний текст джерелаClostridium difficile: Methods and protocols. New York: Humana Press, 2010.
Знайти повний текст джерелаCrowley, Dolores. Cloning virulence factors of clostridium difficile. [S.l: The Author], 1991.
Знайти повний текст джерелаMastrantonio, Paola, and Maja Rupnik, eds. Updates on Clostridium difficile in Europe. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-72799-8.
Повний текст джерелаDubberke, Erik R. Contemporary diagnosis and management of Clostridium difficile infection. Newtown, Pa: Handbooks in Health Care Co., 2011.
Знайти повний текст джерелаChopra, Teena, ed. Clostridium Difficile Infection in Long-Term Care Facilities. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-29772-5.
Повний текст джерелаKetley, Julian Mark. Studies on toxins A and B of Clostridium difficile. Birmingham: University of Birmingham, 1986.
Знайти повний текст джерелаЧастини книг з теми "Clostridium difficile (C. difficile)"
Gerding, Dale N., and Stuart Johnson. "Clostridium difficile." In Bacterial Infections of Humans, 243–51. Boston, MA: Springer US, 1998. http://dx.doi.org/10.1007/978-1-4615-5327-4_13.
Повний текст джерелаCoia, John, and Heather Cubie. "Clostridium difficile." In The Immunoassay Kit Directory, 679–85. Dordrecht: Springer Netherlands, 1995. http://dx.doi.org/10.1007/978-94-009-0359-3_7.
Повний текст джерелаGale, Alexa R., and Matthew Wilson. "Clostridium Difficile." In Gastrointestinal Emergencies, 353–56. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-319-98343-1_101.
Повний текст джерелаSchütt-Gerowitt, Heidi. "Clostridium difficile." In Lexikon der Infektionskrankheiten des Menschen, 175–77. Berlin, Heidelberg: Springer Berlin Heidelberg, 2009. http://dx.doi.org/10.1007/978-3-540-39026-8_199.
Повний текст джерелаWilcox, Mark H. "Clostridium difficile." In Principles and Practice of Clinical Bacteriology, 557–66. Chichester, UK: John Wiley & Sons, Ltd, 2006. http://dx.doi.org/10.1002/9780470017968.ch46.
Повний текст джерелаFriedman, Gerald. "Clostridium difficile." In Mount Sinai Expert Guides, 411–21. Oxford, UK: John Wiley & Sons, Ltd, 2014. http://dx.doi.org/10.1002/9781118932759.ch39.
Повний текст джерелаGerding, Dale N., and Stuart Johnson. "Clostridium difficile." In Bacterial Infections of Humans, 273–82. Boston, MA: Springer US, 2009. http://dx.doi.org/10.1007/978-0-387-09843-2_13.
Повний текст джерелаMagdesian, K. Gary. "Clostridium difficile." In Interpretation of Equine Laboratory Diagnostics, 197–201. Hoboken, NJ, USA: John Wiley & Sons, Inc., 2017. http://dx.doi.org/10.1002/9781118922798.ch35.
Повний текст джерелаAndersen, Bjørg Marit. "Clostridium difficile." In Prevention and Control of Infections in Hospitals, 755–64. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-319-99921-0_53.
Повний текст джерелаVely, Aela P., and Paula Ferrada. "Clostridium difficile Infection." In Emergency General Surgery, 277–81. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-96286-3_23.
Повний текст джерелаТези доповідей конференцій з теми "Clostridium difficile (C. difficile)"
Amarante, Victor Santos do, ISABELA MACEDO DOS SANTOS DE OLIVEIRA, RODRIGO OTÁVIO SILVEIRA SILVA, KELLYANNE DOS ANJOS CARVALHO, and CARLOS AUGUSTO DE OLIVEIRA JUNIOR. "AVALIAÇÃO DE SALMONELLA SPP., CLOSTRIDIUM DIFFICILE E ANCYLOSTOMA SPP. EM FEZES DE CÃES DE MUNICÍPIO SEMIÁRIDO BRASILEIRO." In II Congresso Nacional de Microbiologia Clínica On-line. Revista Multidisciplinar em Saúde, 2022. http://dx.doi.org/10.51161/ii-conamic/58.
Повний текст джерелаLipman, L. J. A., N. E. M. Hopman, and E. C. Keessen. "Clostridium difficile in a farrowing pen." In Ninth International Conference on the Epidemiology and Control of Biological, Chemical and Physical Hazards in Pigs and Pork. Iowa State University, Digital Press, 2011. http://dx.doi.org/10.31274/safepork-180809-624.
Повний текст джерелаBerhane, F., L. Leys, L. Moeng, A. Thomas, and V. Poddar. "Atypical Presentation of Clostridium Difficile Infection." In American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PA. American Thoracic Society, 2020. http://dx.doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a6921.
Повний текст джерелаCama, Valeria, Luisa Pieragostini, Giovanna Fontanelli, Maria Rosa Velletri, and Calafiore Mariarosa. "P387 Clostridium difficile severe infection in a newborn." In Faculty of Paediatrics of the Royal College of Physicians of Ireland, 9th Europaediatrics Congress, 13–15 June, Dublin, Ireland 2019. BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health, 2019. http://dx.doi.org/10.1136/archdischild-2019-epa.733.
Повний текст джерелаMatos, Eduarda Syhara Rocha, Costa, D.V.S., Martins, C.S., Oliveira, L.C., Silva, A.M.H.P., Martins, D.S., Pimentel, P.V.S., and Brito, G.A.C. "Alterações neuroimunes induzidas por toxinas do Clostridium difficile." In II Encontro do Programa de Pós-Graduação em Ciências Farmacêuticas da Universidade Federal do Ceará e I Simpósio Norte-Nordeste de Ciências Farmacêuticas. Fortaleza - CE, Brazil: Galoa, 2017. http://dx.doi.org/10.17648/ppgcf-2017-64895.
Повний текст джерелаThompson, Theresa, and Jay Pasquantonio. "High-intensity UV LED inactivation of Clostridium difficile spores." In Photonic Diagnosis, Monitoring, Prevention, and Treatment of Infections and Inflammatory Diseases 2019, edited by Tianhong Dai, Mei X. Wu, and Jürgen Popp. SPIE, 2019. http://dx.doi.org/10.1117/12.2507993.
Повний текст джерелаHarvey, Roger B., Keri N. Norman, Kathleen Andrews, Bo Norby, Michael E. Hume, and H. Morgan Scott. "Clostridium difficile in pork and retail meat in Texas." In Ninth International Conference on the Epidemiology and Control of Biological, Chemical and Physical Hazards in Pigs and Pork. Iowa State University, Digital Press, 2011. http://dx.doi.org/10.31274/safepork-180809-620.
Повний текст джерелаProhaska, C., and M. F. Ragland. "A Toxic Combination: Clostridium Difficile Infection Leading to Miscarriage." In American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a6573.
Повний текст джерелаRabold, D., A. Schellin, J. Brombach, K. Teske, H. Pischon, L. Mundhenk, M. Fulde, C. Seyboldt, and A. Lübke-Becker. "Reptilien: Ein bislang unterschätztes zoonotisches Risiko für Clostridium difficile-Infektionen?" In 62. Jahrestagung der Fachgruppe Pathologie der Deutschen Veterinärmedizinischen Gesellschaft. Georg Thieme Verlag KG, 2019. http://dx.doi.org/10.1055/s-0039-1688596.
Повний текст джерелаHarvey, Roger B., K. Norman, M. Hume, K. Andrews, H. Scott, B. Norby, C. Scanlan, Robin C. Anderson, and David J. Nisbet. "Survey of Clostridium difficile in Food Animals and Retail Meats." In Eighth International Symposium on the Epidemiology and Control of Foodborne Pathogens in Pork. Iowa State University, Digital Press, 2009. http://dx.doi.org/10.31274/safepork-180809-884.
Повний текст джерелаЗвіти організацій з теми "Clostridium difficile (C. difficile)"
Muldrow, Lycurgus L., and Joe Johnson. Genetic Engineering of Clostridium Difficile Toxin A Vaccine. Fort Belvoir, VA: Defense Technical Information Center, September 1991. http://dx.doi.org/10.21236/ada242265.
Повний текст джерелаMuldrow, Lycurgus L., and Joe Johnson. Genetic Engineering of Clostridium Difficile Toxin a Vaccine. Fort Belvoir, VA: Defense Technical Information Center, August 1990. http://dx.doi.org/10.21236/ada230411.
Повний текст джерелаNeumann, Charlotte, and Uzo Chukwuma. Clostridium difficile Infection in the Department of Defense (DOD): 2007-2013. Fort Belvoir, VA: Defense Technical Information Center, February 2015. http://dx.doi.org/10.21236/ada618664.
Повний текст джерелаGiesen, Christine, Angélica Ortega-Torres, Inmaculada López-Carrillo, Laura López-Vázquez, Carmen María Saa-Requejo, and Cristine García-Fernández. Evolución de la Detección de Clostridium Difficile en un Hospital de Segundo Nivel en Madrid, 2019-2021. Peeref, September 2022. http://dx.doi.org/10.54985/peeref.2209p4674900.
Повний текст джерелаCiapponi, Agustín. What is the effectiveness of interventions to improve antibiotic prescribing practices for hospital inpatients? SUPPORT, 2016. http://dx.doi.org/10.30846/1610132.
Повний текст джерелаMichel, Jeremy, Emilia Flores, Nikhil Mull, and Amy Y. Tsou. Translation of a C. difficile Treatment Clinical Pathway Into Machine-Readable Clinical Decision Support Artifacts Prototyped for Electronic Health Record Integration. Agency for Healthcare Research and Quality (AHRQ), November 2091. http://dx.doi.org/10.23970/ahrqepcmethqualimprcdiff.
Повний текст джерелаFaecal transplant effectively treats recurrent or unresponsive Clostridium difficile. National Institute for Health Research, November 2017. http://dx.doi.org/10.3310/signal-000506.
Повний текст джерела